Spectral Medical (OTCMKTS:EDTXF) Announces Quarterly Earnings Results

Spectral Medical (OTCMKTS:EDTXF) announced its quarterly earnings results on Friday. The company reported ($0.03) earnings per share for the quarter, Zacks reports. The business had revenue of $0.40 million for the quarter.

Spectral Medical Stock Performance

Shares of EDTXF stock opened at $0.62 on Friday. The firm has a market cap of $177.43 million, a P/E ratio of -8.89 and a beta of 0.20. The business’s 50 day moving average price is $0.53 and its 200-day moving average price is $0.44. Spectral Medical has a fifty-two week low of $0.32 and a fifty-two week high of $0.62.

About Spectral Medical

Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream.